Adaptive radiotherapy for locally advanced non-small cell lung cancer: dosimetric gain and treatment outcome prediction

References

• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386.
   PubMed Web of Science ®Google Scholar
• Aupérin A, Le Péchoux C, Rolland E, et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol. 2010;28:2181–2190.
   PubMed Web of Science ®Google Scholar
• Eberhardt WEE, De Ruysscher D, Weder W, et al. 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer. Ann Oncol. 2015;26:1573–1588.
   PubMed Web of Science ®Google Scholar
• Haslett K, Pöttgen C, Stuschke M, et al. Hyperfractionated and accelerated radiotherapy in non-small cell lung cancer. J Thorac Dis. 2014;6:328–335.
   PubMed Web of Science ®Google Scholar
• Bradley JD, Paulus R, Komaki R, et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial. Lancet Oncol. 2015;16:187–199.
   PubMed Web of Science ®Google Scholar
• Ramroth J, Cutter DJ, Darby SC, et al. Dose and fractionation in radiation therapy of curative intent for non-small cell lung cancer: meta-analysis of randomized trials. Int J Radiat Oncol Biol Phys. 2016;96:736–747.
   PubMed Web of Science ®Google Scholar
• Zhang P, Rimner A, Yorke E, et al. A geometric atlas to predict lung tumor shrinkage for radiotherapy treatment planning. Phys Med Biol. 2017;62:702–714.
   PubMed Web of Science ®Google Scholar
• Kong F-M, Ten Haken RK, Schipper M, et al. Effect of midtreatment PET/CT-adapted radiation therapy with concurrent chemotherapy in patients with locally advanced non-small-cell lung cancer. JAMA Oncol. 2017;61:318–328.
   Google Scholar
• Tvilum M, Khalil AA, Møller DS, et al. Clinical outcome of image-guided adaptive radiotherapy in the treatment of lung cancer patients. Acta Oncol. 2015;54:1430–1437.
   PubMed Web of Science ®Google Scholar
• Guckenberger M, Wilbert J, Richter A, et al. Potential of adaptive radiotherapy to escalate the radiation dose in combined radiochemotherapy for locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2011;79:901–908.
   PubMed Web of Science ®Google Scholar
• Korreman S, Rasch C, McNair H, et al. The European Society of Therapeutic Radiology and Oncology-European Institute of Radiotherapy (ESTRO-EIR) report on 3D CT-based in-room image guidance systems: a practical and technical review and guide. Radiother Oncol. 2010;94:129–144.
   PubMed Web of Science ®Google Scholar
• Kwint M, Conijn S, Schaake E, et al. Intra thoracic anatomical changes in lung cancer patients during the course of radiotherapy. Radiother Oncol. 2014;113:392–397.
   PubMed Web of Science ®Google Scholar
• Knap MM, Hoffmann L, Nordsmark M, et al. Daily cone-beam computed tomography used to determine tumour shrinkage and localisation in lung cancer patients. Acta Oncol. 2010;49:1077–1084.
   PubMed Web of Science ®Google Scholar
• Persoon LC, Egelmeer AG, Ollers MC, et al. First clinical results of adaptive radiotherapy based on 3D portal dosimetry for lung cancer patients with atelectasis treated with volumetric-modulated arc therapy (VMAT). Acta Oncol. 2013;52:1484–1489.
   PubMed Web of Science ®Google Scholar
• Kilburn JM, Soike MH, Lucas JT, et al. Image guided radiation therapy may result in improved local control in locally advanced lung cancer patients. Pract Radiat Oncol. 2016;6:e73–e80.
   PubMed Web of Science ®Google Scholar
• Berkovic P, Paelinck L, Lievens Y, et al. Adaptive radiotherapy for locally advanced non-small cell lung cancer, can we predict when and for whom? Acta Oncol. 2015;54:1438–1444.
   PubMed Web of Science ®Google Scholar
• Derycke S, De Gersem WR, Van Duyse BB, et al. Conformal radiotherapy of Stage III non-small cell lung cancer: a class solution involving non-coplanar intensity-modulated beams. Int J Radiat Oncol Biol Phys. 1998;41:771–777.
   PubMed Web of Science ®Google Scholar
• De Ruysscher D, Faivre-Finn C, Nestle U, et al. European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer. JCO. 2010;28:5301–5310.
   PubMed Web of Science ®Google Scholar
• Shin KE, Chung MJ, Jung MP, et al. Quantitative computed tomographic indexes in diffuse interstitial lung disease: correlation with physiologic tests and computed tomography visual scores. J Comput Assist Tomogr. 2011;35:266–271.
   PubMed Web of Science ®Google Scholar
• Guckenberger M, Richter A, Wilbert J, et al. Adaptive radiotherapy for locally advanced non-small-cell lung cancer does not underdose the microscopic disease and has the potential to increase tumor control. Int J Radiat Oncol Biol Phys. 2011;81:e275–e282.
   PubMed Web of Science ®Google Scholar
• Michienzi A, Kron T, Callahan J, et al. Cone-beam computed tomography for lung cancer – validation with CT and monitoring tumour response during chemo-radiation therapy. J Med Imaging Radiat Oncol. 2017;61:263–270.
   PubMed Web of Science ®Google Scholar
• Juhler-Nøttrup T, Korreman SS, Pedersen AN, et al. Interfractional changes in tumour volume and position during entire radiotherapy courses for lung cancer with respiratory gating and image guidance. Acta Oncol. 2008;47:1406–1413.
   PubMed Web of Science ®Google Scholar
• Pantarotto JR, Piet AHM, Vincent A, et al. Motion analysis of 100 mediastinal lymph nodes: potential pitfalls in treatment planning and adaptive strategies. Int J Radiat Oncol. 2009;74:1092–1099.
   PubMed Web of Science ®Google Scholar
• Weiss E, Robertson SP, Mukhopadhyay N, et al. Tumor, lymph node, and lymph node-to-tumor displacements over a radiotherapy series: analysis of interfraction and intrafraction variations using active breathing control (ABC) in lung cancer. Int J Radiat Oncol Biol Phys. 2012;82:e639–e645.
   PubMed Web of Science ®Google Scholar
• Bosmans G, van Baardwijk A, Dekker A, et al. Time trends in nodal volumes and motion during radiotherapy for patients with stage III non-small-cell lung cancer. Int J Radiat Oncol. 2008;71:139–144.
   PubMed Web of Science ®Google Scholar
• Sonke J-J, Belderbos J. Adaptive radiotherapy for lung cancer. Semin Radiat Oncol. 2010;20:94–106.
   PubMed Web of Science ®Google Scholar
• Chun SG, Hu C, Choy H, et al. Impact of intensity-modulated radiation therapy technique for locally advanced non-small-cell lung cancer: a secondary analysis of the NRG oncology RTOG 0617 randomized clinical trial. J Clin Oncol. 2017;35:56–62.
   PubMed Web of Science ®Google Scholar
• Speirs CK, DeWees TA, Rehman S, et al. Heart dose is an independent dosimetric predictor of overall survival in locally advanced non–small cell lung cancer. J Thorac Oncol. 2017;12:293–301.
   PubMed Web of Science ®Google Scholar
• Jabbour SK, Kim S, Haider SA, et al. Reduction in tumor volume by cone beam computed tomography predicts overall survival in non-small cell lung cancer treated with chemoradiation therapy. Int J Radiat Oncol. 2015;92:627–633.
   PubMed Web of Science ®Google Scholar